Qsymia (phentermine/topiramate) is FDA-approved for chronic weight management in adults and children with obesity, or overweight and a weight-related health condition
Over 56 weeks, the average weight loss on the maintenance dose (3mg) of liraglutide is 8%
This activation results in several beneficial effects mimicking the hormone's natural functions
not FDA-approved) use that aims to achieve the therapeutic benefits of the medication, including appetite suppression and improved metabolic health, while significantly reducing the risk and severity of common side effects, which can include issues like bloating, diarrhea, nausea, vomiting, and more
Shes been working with her doctor to incorporate more protein, which can help combat the muscle loss that often accompanies significant weight loss
Ultimately, the duration of use will depend on the dose tolerance, overall health, personal health goals, and the doctors advice